JWH-147

JWH-147 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is somewhat selective for the CB2 subtype, with a Ki of 11.0 nM at CB1 vs 7.1 nM at CB2.[1] It was discovered and named after John W. Huffman.

JWH-147
Legal status
Legal status
  • UK: Class B
  • US: Schedule I
  • Illegal in Sweden
Identifiers
CAS Number
ChemSpider
Chemical and physical data
FormulaC27H27NO
Molar mass381.519 g·mol−1
3D model (JSmol)
 NY (what is this?)  (verify)

In the United States, CB1 receptor agonists of the 3-(1-naphthoyl)pyrrole class such as JWH-147 are Schedule I Controlled Substances.[2]

JWH-147 was banned in Sweden on 1 October 2010 as harmful to health, after being identified as an ingredient in "herbal" synthetic cannabis products.[3][4]

See also

References
  1. Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorganic & Medicinal Chemistry Letters 2006; 16:5432-5435.
  2. 21 U.S.C. § 812: Schedules of controlled substances
  3. Swedish Code of Statutes Regulation (2010:1086).
  4. Swedish Code of Statutes Regulation (2010:1086). (pdf)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.